| 引用本文: |
朱玄,杨金凤,王萍.美国终末期肾病质量激励计划的实施经验与启示[J].中国卫生经济,2023,42(6):93-96.[点击复制] |
ZHU Xuan,YANG Jin-feng,WANG Ping.The End-Stage Renal Disease Quality Incentive Program in U.S. and Its Implications[J].CHINESE HEALTH ECONOMICS,2023,42(6):93-96.[点击复制] |
|
| 摘要: |
| 美国终末期肾病质量激励计划(QIP)将医疗服务质量与医保支付相结合，是按绩效付费和价值购买体系中的代表性项目。文章通过阐述美国QIP的实施经验，包括理念发展、指标体系、评分方法、支付扣减等，总结实践经验，为我国医保支付方式改革乃至医疗卫生体制改革地深化提供借鉴和参考。 |
| 关键词: 终末期肾病 质量激励计划 美国 综述 |
| DOI： |
| 投稿时间：2023-05-06 |
| 基金项目:天津市第一中心医院天津 300190 |
|
| The End-Stage Renal Disease Quality Incentive Program in U.S. and Its Implications |
| ZHU Xuan,YANG Jin-feng,WANG Ping |
| (Tianjin First Center Hospital,Tianjin 300190 ,China) |
| Abstract: |
| The end-stage renal disease quality incentive plan(QIP) in the United States，which links the quality of medical services with provider payment，is a representative project in the pay-for-performance and value-based purchase system. To provide references for the reform of China's provider payment mode and healthcare system，it summarizes the practical experience of the implementation of QIP in the U.S，including concept development，indicator system，scoring method and payment deduction. |
| Key words: end-stage renal disease quality incentive program US. review |
